Jeffery Kutok - 11 Apr 2022 Form 4 Insider Report for Epizyme, Inc.

Role: Chief Scientific Officer
Signature: /s/ John Weidenbruch, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 11 Apr 2022
Net transactions value: -$2,467
Form type: 4
Filing time: 13 Apr 2022, 17:49:11 UTC
Previous filing: 21 Mar 2022
Next filing: 11 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPZM	Common Stock, par value $0.0001	Sale	$2,467	-2,741	-2.8%	$0.9000	94,563	11 Apr 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units granted under the Company's 2013 Stock Incentive Plan on April 1, 2020. The automatic sale of the reporting person's shares of Common Stock is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.

Content

Represents shares of Common Stock automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units granted under the Company's 2013 Stock Incentive Plan on April 1, 2020. The automatic sale of the reporting person's shares of Common Stock is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.